Decision Support and Navigation to Increase Colorectal Cancer Screening Among Hispanic Patients.


Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608

Informations de publication

Date de publication:
02 2019
Historique:
received: 30 03 2018
revised: 22 06 2018
accepted: 09 10 2018
pubmed: 20 10 2018
medline: 14 4 2020
entrez: 19 10 2018
Statut: ppublish

Résumé

Effective strategies are needed to raise colorectal cancer screening rates among Hispanics. We surveyed and randomized 400 Hispanic primary care patients either to a Decision Support and Navigation Intervention (DSNI) Group ( Screening adherence was significantly higher in the DSNI Group than the SI Group [OR, 4.8; 95% confidence interval (CI), 3.1-7.6]. The DSNI Group, compared with the SI Group, also displayed higher SBT screening [OR, 4.2; 95% CI, 2.6-6.7), higher colonoscopy screening (OR, 8.8; 95% CI, 4.1-18.7), and greater forward change in screening decision stage (OR, 4.9; 95% CI, 2.6-9.5). At endpoint, study groups did not differ in screening knowledge or perceptions. The DSNI had a greater positive impact on colorectal cancer screening outcomes than the SI. Health system implementation of DSNI strategies may help to reduce Hispanic colorectal cancer screening disparities in primary care.

Sections du résumé

BACKGROUND
Effective strategies are needed to raise colorectal cancer screening rates among Hispanics.
METHODS
We surveyed and randomized 400 Hispanic primary care patients either to a Decision Support and Navigation Intervention (DSNI) Group (
RESULTS
Screening adherence was significantly higher in the DSNI Group than the SI Group [OR, 4.8; 95% confidence interval (CI), 3.1-7.6]. The DSNI Group, compared with the SI Group, also displayed higher SBT screening [OR, 4.2; 95% CI, 2.6-6.7), higher colonoscopy screening (OR, 8.8; 95% CI, 4.1-18.7), and greater forward change in screening decision stage (OR, 4.9; 95% CI, 2.6-9.5). At endpoint, study groups did not differ in screening knowledge or perceptions.
CONCLUSIONS
The DSNI had a greater positive impact on colorectal cancer screening outcomes than the SI.
IMPACT
Health system implementation of DSNI strategies may help to reduce Hispanic colorectal cancer screening disparities in primary care.

Identifiants

pubmed: 30333221
pii: 1055-9965.EPI-18-0260
doi: 10.1158/1055-9965.EPI-18-0260
doi:

Banques de données

ClinicalTrials.gov
['NCT02272244']

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

384-391

Informations de copyright

©2018 American Association for Cancer Research.

Auteurs

Ronald E Myers (RE)

Division of Population Science, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. ronald.myers@jefferson.edu.

Brian Stello (B)

Lehigh Valley Health Network, Allentown, Pennsylvania.

Constantine Daskalakis (C)

Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania.

Randa Sifri (R)

Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.

Evelyn T González (ET)

Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Melissa DiCarlo (M)

Division of Population Science, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.

Melanie B Johnson (MB)

Lehigh Valley Health Network, Allentown, Pennsylvania.

Sarah E Hegarty (SE)

Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania.

Kyle Shaak (K)

Lehigh Valley Health Network, Allentown, Pennsylvania.

Alicia Rivera (A)

Lehigh Valley Health Network, Allentown, Pennsylvania.

Lucas Gordils-Molina (L)

Lehigh Valley Health Network, Allentown, Pennsylvania.

Anett Petrich (A)

Division of Population Science, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.

Beth Careyva (B)

Lehigh Valley Health Network, Allentown, Pennsylvania.

Rosa de-Ortiz (R)

Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Liselly Diaz (L)

Lehigh Valley Health Network, Allentown, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH